Correlation Between Zevia Pbc and Sangui Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zevia Pbc and Sangui Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zevia Pbc and Sangui Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zevia Pbc and Sangui Biotech International, you can compare the effects of market volatilities on Zevia Pbc and Sangui Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zevia Pbc with a short position of Sangui Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zevia Pbc and Sangui Biotech.

Diversification Opportunities for Zevia Pbc and Sangui Biotech

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Zevia and Sangui is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Zevia Pbc and Sangui Biotech International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangui Biotech Inter and Zevia Pbc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zevia Pbc are associated (or correlated) with Sangui Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangui Biotech Inter has no effect on the direction of Zevia Pbc i.e., Zevia Pbc and Sangui Biotech go up and down completely randomly.

Pair Corralation between Zevia Pbc and Sangui Biotech

Given the investment horizon of 90 days Zevia Pbc is expected to generate 0.76 times more return on investment than Sangui Biotech. However, Zevia Pbc is 1.31 times less risky than Sangui Biotech. It trades about 0.32 of its potential returns per unit of risk. Sangui Biotech International is currently generating about -0.13 per unit of risk. If you would invest  109.00  in Zevia Pbc on November 2, 2024 and sell it today you would earn a total of  324.00  from holding Zevia Pbc or generate 297.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Zevia Pbc  vs.  Sangui Biotech International

 Performance 
       Timeline  
Zevia Pbc 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Zevia Pbc are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak forward indicators, Zevia Pbc sustained solid returns over the last few months and may actually be approaching a breakup point.
Sangui Biotech Inter 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sangui Biotech International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Zevia Pbc and Sangui Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zevia Pbc and Sangui Biotech

The main advantage of trading using opposite Zevia Pbc and Sangui Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zevia Pbc position performs unexpectedly, Sangui Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangui Biotech will offset losses from the drop in Sangui Biotech's long position.
The idea behind Zevia Pbc and Sangui Biotech International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device